TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
Cardiovascular diseases remain the most common cause of death in Russia. In real clinical practice doctors are more focused on the modification of other major risk factors rather than on the correction of dyslipidemia, or pay more attention to secondary prevention of cardiovascular diseases.Aim. To...
Saved in:
Main Authors: | V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/140 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01) -
Safety of combined hypolypidemic therapy in clinical practice
by: A. O. Gukov, et al.
Published: (2025-06-01) -
MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
by: I. N. Medvedev
Published: (2017-05-01) -
Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01) -
RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
by: Advisory Board
Published: (2017-06-01)